hero-banner-image

TOGETHER, WE'VE GOT THIS.

Patients Can't Wait. Neither Can We.™

Learn More

New Virtual Event: April 15

Advancing Your Neurodegenerative Biomarker Strategy Beyond Discovery

The challenges of new medicine identification are daunting enough--your biomarker strategy doesn't have to make it even more complex. Attend our upcoming virtual workshop and find out how you can effectively and efficiently incorporate biomarkers into clinical trials, so you can more quickly deliver the medicines that help patients struggling with neurodegenerative disorders like Alzheimer's and Parkinson's disease.

RECOGNITION

Covance named 2020 Global CRO Company of the Year by Frost & Sullivan 

As pharma and biotech sponsors increasingly rely on contract research organizations (CROs) for cost-effective and time-efficient drug development, Frost & Sullivan has analyzed which CROs are helping sponsors navigate clinical trials, meeting changing regulatory guidelines, expediting development and rapidly adopting new technologies. Congrats to our global team members for helping us make a difference for our sponsors – and patients around the world – to earn the honor of the 2020 Global CRO Company of the Year Award. 

A Transformational Approach to Clinical Trials

Labcorp Transforms the Clinical Trial Experience to Streamline its Drug Development Process

Company goes beyond decentralized clinical trials to deliver seamless tech-enabled, patient-centric enterprise solutions. Labcorp now offers a comprehensive and fully integrated patient, site, and customer experience for DCTs.

Covance announces acquisition of snapIoT

Covance announces acquisition of snapIoT

Labcorp has announced that Covance has completed the transaction to acquire snapIoT, the fastest growing platform as a service provider of mobile-connected self-service platform solutions. This acquisition enables Covance to offer highly configurable and inter-operable patient centric solutions that enable remote participation in clinical trials, reduce patient burden while speeding implementation and improving data quality.

We’re in this together

COVID-19

Whether you are developing a COVID-19 assay, a vaccine to prevent patients from getting COVID-19, an antiviral or a treatment to mitigate the severe immunological response (cytokine storm) associated with COVID-19, we can partner with you to provide critical drug development and diagnostic services to address the global pandemic.

News

Covance Announces Acquisition of GlobalCare Clinical Trials, LLC

Labcorp has announced that Covance has completed the transaction to acquire GlobalCare, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs). The acquisition of GlobalCare will expand the Covance DCTs offering into global markets and help us meet your growing demand for patient-centric trial designs.  

#COVANCEPOTENTIAL

It's not just a job. To us, it's personal.

Covance, the drug development business of Labcorp, is recognized as a leader in drug development because of our exceptional people. We embrace and celebrate the different strengths, experiences and perspectives of our 65,000+ enterprise team members across the globe. Our team is driven by an energizing purpose to improve health and improve lives. Here, you can play a role in bringing new scientific discoveries to life and make a difference in the lives of millions. Join us and discover your extraordinary potential.
 

Covance by the Numbers

Annual Encounters 160M Patients
Supports Clinical Trials in 100+ Countries
Collaborated on 100% Novel Oncology Drugs
Helped Develop 86% Rare & Orphan Drugs

Contributed in the development of all the current top 50 drugs on the market

Covance Insights

COVID-19: vaccine innovation and safety at pandemic speed
COVID-19: vaccine innovation and safety at pandemic speed
Blog Posts
The global spread of COVID-19 and its great impact on the health and wellbeing of our population has imposed a race to develop an effective vaccine at unprecedented speed. A development process that usually spans several years is being compressed into one year - or less. Safety is a vital part of this process, and so we identified and discussed several key factors and considerations around safety in vaccine development. This article provides a synopsis of our insights.
Read More
Closing the Gap in Pediatric Oncology Drug Development: The Regulatory Landscape and the RACE for Children Act
Closing the Gap in Pediatric Oncology Drug Development: The Regulatory Landscape and the RACE for Children Act
Articles
The current regulatory environment can help support sponsors with the complex efforts involved in pediatric oncology drug development, as regulatory agencies and legislative acts have helped encourage, incentivize or even require the conduct of pediatric trials in other indications. This white paper provides a brief history of how pediatric cancer treatments have progressed, outlines how regulatory changes have impacted the field of pediatric drug development and provides guidance on applying current regulations, such as the RACE for Children Act which is focused on pediatric oncology. This change should serve to enhance an inclusive regulatory strategy for oncologic drug development.
Read More
Medical Device and Diagnostic Solutions: Preclinical and Experimental Surgery
Medical Device and Diagnostic Solutions: Preclinical and Experimental Surgery
Info Sheets
Craft the optimal preclinical strategy by collaborating with our medical device development specialists. Then access the preclinical resources necessary to make your initial development stage easier. Whether you are exploring a promising device concept, initiating a comprehensive testing plan or conducting a single study, Covance Medical Device and Diagnostic Solutions can help you prove out your device in its earliest stage of development.
Read More
Patient-Centric Field Reimbursement Quadruples Enrollment, Increases Stakeholder Satisfaction
Patient-Centric Field Reimbursement Quadruples Enrollment, Increases Stakeholder Satisfaction
Articles
A top-5 pharmaceutical company partnered with Covance to provide field reimbursement management (FRM) services for their autoimmune infusion therapy program. Learn more about how Covance played a critical role in facilitating enrollment and stakeholder satisfaction.
Read More

Stay up to date with the latest news from Covance

Subscribe Now

Learn More